7N0A
Structure of Human Leukaemia Inhibitory Factor with Fab MSC1
Summary for 7N0A
Entry DOI | 10.2210/pdb7n0a/pdb |
Descriptor | Leukemia inhibitory factor, MSC-1 Fab Light chain, MSC-1 Fab Heavy chain, ... (7 entities in total) |
Functional Keywords | lif, cytokine, antibody, cancer therapeutics, cytokine-immune system complex, cytokine/immune system |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 3 |
Total formula weight | 69317.99 |
Authors | Raman, S.,Bosch, A.,Fransson, J.,Julien, J.P. (deposition date: 2021-05-25, release date: 2022-06-15, Last modification date: 2024-10-09) |
Primary citation | Hallett, R.M.,Bonfill-Teixidor, E.,Iurlaro, R.,Arias, A.,Raman, S.,Bayliss, P.,Egorova, O.,Neva-Alejo, A.,McGray, A.R.,Lau, E.,Bosch, A.,Beilschmidt, M.,Maetzel, D.,Fransson, J.,Huber-Ruano, I.,Anido, J.,Julien, J.P.,Giblin, P.,Seoane, J. Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment. Clin.Cancer Res., 29:791-804, 2023 Cited by PubMed Abstract: Leukemia inhibitory factor (LIF) is a multifunctional cytokine with numerous reported roles in cancer and is thought to drive tumor development and progression. Characterization of LIF and clinical-stage LIF inhibitors would increase our understanding of LIF as a therapeutic target. PubMed: 36441800DOI: 10.1158/1078-0432.CCR-21-1888 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.1 Å) |
Structure validation
Download full validation report
